Primary Site >> Colorectal Cancer
Gene >> PLAT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Clinical study on tissue polypeptide antigen (TPA) as a tumor marker]. PMID: 6201629 Ref: [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer]. PMID: 6481966 |
Ref: [Clinical utility of tumor markers in gastric and colon cancer]. PMID: 3861884 Ref: Combination of tissue polypeptide antigen (TPA) and carcino embryonic antigen (CEA) in different types of cancer. PMID: 4034127 |
Ref: [Clinical evaluation of tumor markers in patients with colorectal cancer]. PMID: 2444727 Ref: Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery. PMID: 3470172 Ref: Neopterin. A tumor marker in colorectal carcinoma? PMID: 3479311 |
Ref: The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer. PMID: 2693562 Ref: Preoperative prediction of late cancer-specific deaths in patients with rectal and rectosigmoid carcinoma. PMID: 2769002 |
Ref: Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. PMID: 1702928 Ref: Gastrointestinal cancer follow-up: the effectiveness of sequential CEA, TPA and Ca 19-9 evaluation in the early diagnosis of recurrences. PMID: 1877936 |
Ref: [Tumor markers in colorectal cancer]. PMID: 1407623 Ref: [Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer]. PMID: 1507478 |
Ref: Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. PMID: 8097582 |
Ref: Clinical profile of a new monoclonal antibody-based immunoassay for tissue polypeptide antigen. PMID: 7836801 Ref: Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. PMID: 7872665 Ref: [Measurement of serum tissue-polypeptide antigen (TPA) levels by EIA employing monoclonal antibody]. PMID: 8185344 |
Ref: Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. PMID: 7557947 |
Ref: [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit]. PMID: 8645025 Ref: Inhibitory effect of a spicamycin derivative, KRN5500, on the growth of hepatic metastasis of human colon cancer-producing tissue polypeptide antigen. PMID: 8823489 Ref: Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. PMID: 8826859 Ref: Stress responses to DNA damaging agents in the human colon carcinoma cell line, RKO. PMID: 8950345 Ref: Expression of tissue-type plasminogen activator, plasminogen activator inhibitor and von Willebrand factor in the supernatant of endothelial cell cultures in response to the seeding of adenocarcinoma cell line HRT-18. PMID: 8952858 |
Ref: TPA induces transglutaminase C and inhibits cell growth in the colon carcinoma cell line SW620. PMID: 9126346 |
Ref: Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer. PMID: 10419057 Ref: The role of cysteine and serine proteases in colorectal carcinoma. PMID: 10506696 |
Ref: Tissue-type plasminogen activator (tPA) content in colorectal cancer and in surrounding mucosa: relationship with clinicopathologic parameters and prognostic significance. PMID: 10763140 |
Ref: Prevention of intra-abdominal adhesions by using Seprafilm in rats undergoing bowel resection and radiation therapy. PMID: 12791018 |
Ref: NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. PMID: 15254653 Ref: [Gastrointestinal cancer]. PMID: 15332558 Ref: Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasiveness. PMID: 15375554 |
Ref: Matrilysin (matrix metalloprotease-7) cleaves membrane-bound annexin II and enhances binding of tissue-type plasminogen activator to cancer cell surfaces. PMID: 18721140 |
Ref: Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival. PMID: 21173292 |
Ref: The plasminogen activator inhibitor system in colon cancer cell lines is influenced by the CO2 pneumoperitoneum. PMID: 20931209 Ref: Clinical relevance of uPA, uPAR, PAI 1 and PAI 2 tissue expression and plasma PAI 1 level in colorectal carcinoma patients. PMID: 22234062 |
Ref: Modifying neurorepair and neuroregenerative factors with tPA and edaravone after transient middle cerebral artery occlusion in rat brain. PMID: 22221736 |
Ref: Prognostic role of tumor-associated proteases in colorectal cancer. PMID: 23484202 Ref: Tumor associated proteases -- prognostic markers of colorectal cancer. PMID: 24640092 |
Ref: Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer. PMID: 24674880 |
Ref: Radiation promotes colorectal cancer initiation and progression by inducing senescence-associated inflammatory responses. PMID: 26477319 |
Ref: Analyzing the molecular mechanism of the tissue specificity of gastrointestinal stromal tumors by using bioinformatics approaches. PMID: 30358224 |